Introduction
Natural killer (NK)' cells are large granular lymphocytes that are capable of IFN-y production in response to infection. This effector function does not require prior sensitization, suggesting that NK cells may play an important role in the early innate immune response to microbial invasion (1, 2) . Indeed, it has been shown in a number of in vitro and in vivo experimental systems that NK cell production of IFN-y is critical for the control of several intracellular pathogens. This phenomenon has been best examined by studying monocytes infected with 1 . Abbreviations used in this paper: HAB, human AB; hu, human; NK, natural killer; R, receptor; rh, recombinant human.
Methods
Reagents and antibodies. Purified LPS from Escherichia coli strain 0127:B8 was purchased from Sigma Chemical Co. (St. Louis, MO). Rabbit anti-human (hu) IL-15 antiserum and rabbit anti-huIL-2 antiserum were obtained from Pepro Tech, Inc. (Rocky Hill, NJ) and were produced after serial immunization of rabbits with purified rhIL-15 and rhIL-2, respectively. A rabbit anti-murine IL-3 antiserum (Pepro Tech, Inc.) was used as a nonreactive control. All three antisera were purified by ammonium sulfate precipitation followed by ion exchange chromatography and were used at a concentration of 5 jig/ml unless otherwise specified. The anti-huIL-15 antiserum was tested for specificity in a CD56bght NK cell proliferation assay and CD56+NK cell IFN-y production assay (13) , and was found to neutralize the activity of rhIL-15 but did show any cross-reactivity with rhIL-2, rhIL-1,f, rhTNF-a or rhIL-12. At a concentration of 5 jqg/ml, anti-huIL-15 antiserum neutralized 75% of the bioactivity induced by 10 ( 12, 15, 16) . Neutralizing rabbit anti-huIL-12 antiserum was kindly provided by Dr. Stanley Wolf (Genetics Institute, Andover, MA) and was used 1 2 3 4 5 6 7 13 kD -_ -(Ajinomoto Co., Kawasaki, Japan) (17) . Reagents used for the immunomagnetic depletion of PBMC have been described (18) .
Isolation of human NK cells and monocytes. CD56 + CD3 -human NK cells were purified from fresh leukopacs (American Red Cross, Buffalo, NY) by cell sorting (2 97% purity) as previously described (18) . Human monocytes from the same donors were isolated after a 2-h plastic adherence as described by D'Andrea et al. (19) . To remove the adhered monocytes, the plastic plate was repeatedly sprayed with a 25-gauge needle attached to a 12-cm3 syringe containing cold RPM! 1640 medium. Cells were always found to be > 95% CD14+ by flow cytometry.
Detection of IL-15 protein by immunohistochemistry. For immunohistochemical and Western blot analysis, purified human monocytes were incubated for 5 h in the presence or absence of LPS (5 ag/ml). Cells for staining were resuspended in medium containing 10% human AB (HAB) serum and 50% human albumin, cytocentrifuged onto silanecoated slides (Oncor Inc., Gaithersburg, MD), and placed into fixative (2% paraformaldehyde, 0.1 M lysine, 0.1 M Na2PO4, 10 mM NaIO4) for 15 min at 4°C. Cytospin preparations were next treated with blocking solutions as described (20) , followed by incubation with anti-huIL-15 mAb (MI 10) or an isotype control mAb (Sigma). Bound primary mAbs were then detected using a biotinylated goat anti-mouse IgG avidinhorseradish peroxidase complex and diamino benzidine substrate, followed by counterstaining and mounting as described (20 Fig. 1, A and B , demonstrate huIL-15 protein production after 5 h of LPS activation. Resting monocytes were negative for IL-15 protein (not shown). The results were verified by immunoblot analysis using an anti-huIL-15 antiserum distinct from that used for immunohistochemical staining (Fig. 1 C) .
Coculture of human NK cells with activated human monocytes results in IFN-y production. T (Fig. 2 A) . Coculture of unstimulated monocytes with unstimulated NK cells did not induce IFN--y production. However, when monocytes and NK cells were cocultured in the presence of LPS, IFN-y was easily detectable in culture supernatants at 72 h (Fig. 2 A) . Thus, LPS activation of human monocytes induces IFN-y production in NK cells.
We next measured the kinetics of IFN-y production during coculture of LPS-activated monocytes and NK cells. IFN-y was detected in culture supernatants 18 h after the addition of LPS, peaked in concentration at 48 h, and underwent a significant decline by 96 h (Fig. 2 B) . A fourfold increase in the number of monocytes per well in these cocultures resulted in a 300% increase in IFN--y protein production (not shown). The actual production of IFN-y in cocultures of LPS-activated monocytes and NK cells varied approximately fivefold between different donors.
Endogenous IL-IS production by human monocytes is critical for optimal NK cell IFN--y production. The kinetics and quantity of IL-15 production in this coculture system were determined by ELISA and compared to IL-12 protein production in the same culture. As can be seen in Fig. 3 A, significant levels of IL-15 and IL-12 are produced within 24 h of LPS activation. We next investigated whether endogenous IL-15 production by LPS-activated human monocytes was contributing to IFNy secretion by human NK cells. Cocultures of LPS-activated monocytes and NK cells were treated with neutralizing antihuIL-15 antiserum or control antiserum. Culture in the presence of neutralizing anti-huIL-15 antiserum resulted in a 77% decrease in IFN-y production as compared to a control antiserum (Fig. 3 A) . IFN-y production could also be partially inhibited in the presence of an anti-IL-2R,6 mAb (68% reduction, Fig.   3 B) , while an anti-huIL-2 neutralizing antiserum had no significant effect (Fig. 3 C) . It is noteworthy that while endogenous IL-15 is required for optimal IFN--y production, complete abrogation was never achieved with higher concentrations of anti-huIL-15 antiserum or anti-huIL-2R,/ mAb (data not shown). This suggests that suboptimal amounts of IFN-y can be produced by NK cells in the presence of other monocytederived cytokines (4) (5) (6) . In data not shown, complete neutralization of hu1L-12 alone reproducibly abolished IFN-y produc- tion in this coculture system (94.3%±2.4 reduction, P < 0.0005 for n = 5 experiments).
Discussion
In whereas an anti-IL-2 neutralizing antisera had no effect. This finding supports our previous observation that rhIL-15 interacts with the ,3 subunit of the IL-2R to activate human NK cells (13) . Other combinations of endogenously produced monocytederived cytokines can induce IFN--y production by NK cells in the absence of IL-15, including IL-12, TNF-a, and IL-1,6 (4) (5) (6) 14) . Indeed, the combination of rhIL-12 and rTNF-a induces suboptimal IFN-y production in purified human NK cells compared with rhIL-12 plus rhIL-15 (Carson, W. E., unpublished observations). Thus, rhIL-12 can combine with either rhIL-15 or rhTNF-a to induce IFN-y secretion by NK cells, whereas the combination of rhIL-15 and rhTNF-a is not effective (13) . IL-12 therefore appears to be the pivotal cytokine in the NK cell IFN-y response, but costimulation with IL-15 is required for optimal production. Further, just as some pathogens evade eradication by their failure to induce TNF-a or IL-12 secretion by monocytes (22, 23) , others may eventually be found to evade detection by not for virtually all antimicrobial and antiparasitic activities (24) and is only produced by T cells and NK cells (21) . NK cells appear to be critical in the early defense against many of these pathogens by supplying IFN-y after activation by monocytederived cytokines such as TNF-a and IL-12. Our work suggests that IL-15 is an important monocyte-derived cytokine required for optimal production of IFN-y by human NK cells. As such, it is likely to have a significant role during the innate immune response to certain infections in vivo. Its production by activated human monocytes provides additional insight as to why NK cells constitutively express a functional IL-2 receptor.
